CITED4 gene therapy: Can it be cited for preventing maladaptive post-ischemic cardiac remodeling?
作者信息
Nording Henry, Müller Oliver J
机构信息
Department of Internal Medicine V, University of Kiel, and German Centre for Cardiovascular Research, Partner Site Hamburg/Kiel/Lübeck, Kiel, Germany; DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Lübeck/Kiel, 23562 Lübeck, Germany.
Department of Internal Medicine V, University of Kiel, and German Centre for Cardiovascular Research, Partner Site Hamburg/Kiel/Lübeck, Kiel, Germany; DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Lübeck/Kiel, 23562 Lübeck, Germany.
出版信息
Mol Ther. 2024 Oct 2;32(10):3217-3219. doi: 10.1016/j.ymthe.2024.09.012. Epub 2024 Sep 23.
Abstract
摘要
相似文献
1
CITED4 gene therapy: Can it be cited for preventing maladaptive post-ischemic cardiac remodeling?
Mol Ther. 2024 Oct 2;32(10):3217-3219. doi: 10.1016/j.ymthe.2024.09.012. Epub 2024 Sep 23.
2
CITED4 gene therapy protects against maladaptive cardiac remodeling after ischemia/reperfusion injury in mice.
Mol Ther. 2024 Oct 2;32(10):3683-3694. doi: 10.1016/j.ymthe.2024.07.018. Epub 2024 Jul 26.
3
Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation.
Circ Heart Fail. 2010 Sep;3(5):627-34. doi: 10.1161/CIRCHEARTFAILURE.109.891184. Epub 2010 Jul 15.
4
CITED4 Protects Against Adverse Remodeling in Response to Physiological and Pathological Stress.
Circ Res. 2020 Aug 14;127(5):631-646. doi: 10.1161/CIRCRESAHA.119.315881. Epub 2020 May 18.
5
miRNAs as therapeutic targets in ischemic heart disease.
J Cardiovasc Transl Res. 2010 Jun;3(3):280-9. doi: 10.1007/s12265-010-9173-y. Epub 2010 Mar 30.
6
Adeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling.
J Gene Med. 2012 Sep-Oct;14(9-10):609-20. doi: 10.1002/jgm.2673.
7
Molecular aspects of ischemic heart disease: ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy.
J Cardiovasc Pharmacol Ther. 2006 Mar;11(1):17-30. doi: 10.1177/107424840601100102.
8
Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac function.
FASEB J. 2020 Aug;34(8):9911-9924. doi: 10.1096/fj.201903074RR. Epub 2020 May 19.
9
MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease.
J Mol Cell Cardiol. 2017 Nov;112:27-39. doi: 10.1016/j.yjmcc.2017.08.013. Epub 2017 Sep 1.
10
Exercise-induced CITED4 expression is necessary for regional remodeling of cardiac microstructural tissue helicity.
Commun Biol. 2022 Jul 4;5(1):656. doi: 10.1038/s42003-022-03635-y.
本文引用的文献
1
CITED4 gene therapy protects against maladaptive cardiac remodeling after ischemia/reperfusion injury in mice.
Mol Ther. 2024 Oct 2;32(10):3683-3694. doi: 10.1016/j.ymthe.2024.07.018. Epub 2024 Jul 26.
2
Current RNA strategies in treating cardiovascular diseases.
Mol Ther. 2024 Mar 6;32(3):580-608. doi: 10.1016/j.ymthe.2024.01.028. Epub 2024 Jan 29.
3
Transcriptional Targeting Approaches in Cardiac Gene Transfer Using AAV Vectors.
Pathogens. 2023 Oct 30;12(11):1301. doi: 10.3390/pathogens12111301.
4
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
5
Exercise and cardiac health: physiological and molecular insights.
Nat Metab. 2020 Sep;2(9):829-839. doi: 10.1038/s42255-020-0262-1. Epub 2020 Aug 17.
6
From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases.
Eur Heart J. 2020 Oct 21;41(40):3884-3899. doi: 10.1093/eurheartj/ehaa229.
7
CITED4 induces physiologic hypertrophy and promotes functional recovery after ischemic injury.
JCI Insight. 2016 Jun 16;1(9). doi: 10.1172/jci.insight.85904.
8
Targeting Myocardial Reperfusion Injury--The Search Continues.
N Engl J Med. 2015 Sep 10;373(11):1073-5. doi: 10.1056/NEJMe1509718. Epub 2015 Aug 30.
9
miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling.
Cell Metab. 2015 Apr 7;21(4):584-95. doi: 10.1016/j.cmet.2015.02.014.
10
Potential novel pharmacological therapies for myocardial remodelling.
Cardiovasc Res. 2009 Feb 15;81(3):519-27. doi: 10.1093/cvr/cvn317. Epub 2008 Nov 19.
Zotero 插件